Loading insider details...
Latest Form 4 (Apr 23, 2026): Disposition to Issuer of 312,025 DAWN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Apr 23, 2026 | Day One Biopharmaceuticals, Inc. (DAWN) | Disposition to Issuer | 312,025 | n/a |
| Feb 18, 2026 | Day One Biopharmaceuticals, Inc. (DAWN) | Exercise/Conversion | 2,250 | n/a |
| Jan 30, 2026 | Day One Biopharmaceuticals, Inc. (DAWN) | Grant/Award | 188,000 | n/a |
| Nov 19, 2025 | Day One Biopharmaceuticals, Inc. (DAWN) | Exercise/Conversion | 1,375 | n/a |
| Nov 7, 2025 | Day One Biopharmaceuticals, Inc. (DAWN) | Disposition to Issuer | 497,667 | n/a |
| Aug 19, 2025 | Day One Biopharmaceuticals, Inc. (DAWN) | Exercise/Conversion | 1,375 | n/a |
| May 19, 2025 | Day One Biopharmaceuticals, Inc. (DAWN) | Exercise/Conversion | 1,375 | n/a |
| Feb 21, 2025 | Day One Biopharmaceuticals, Inc. (DAWN) | Exercise/Conversion | 1,375 | n/a |
| Jan 31, 2025 | Day One Biopharmaceuticals, Inc. (DAWN) | Grant/Award | 162,000 | n/a |
| Nov 19, 2024 | Day One Biopharmaceuticals, Inc. (DAWN) | Exercise/Conversion | 1,375 | n/a |